Does colchicine reduce the rate of incessant or recurrent pericarditis in patients with acute pericarditis?
In patients with acute pericarditis, the addition of colchicine to conventional antiinflammatory therapy significantly reduces the risk of incessant or recurrent pericarditis.
In patients with acute pericarditis, colchicine, when added to conventional antiinflammatory therapy, significantly reduced the rate of incessant or recurrent pericarditis. (Funded by former Azienda Sanitaria Locale 3 of Turin now Azienda Sanitaria Locale 2 and Acarpia; ICAP ClinicalTrials.gov number, NCT00128453.).
Imazio et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: